NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Duchenne UK

Duchenne UK

Overview

Duchenne UK is a UK-based medical research charity that funds and accelerates research and the development of treatments to end Duchenne muscular dystrophy (DMD).

Year Founded

2012

Portfolio Companies

4

Investments

Duchenne UK investments
CompanyDateStageLead
Myogenica, Inc.Apr 2024GrantCo-investor
MetrioPharm AGOct 2022GrantLead
EVOX GlobalNov 2018GrantCo-investor
Evox TherapeuticsNov 2018GrantCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon
Year Founded2012

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.